|
Media Contact
Annette Ballou
Email
216.658.3999
|
|
|
|
|
Newsroom > News
|
|
|
BioMotiv, LLC today announced the launch of operations with headquarters in Cleveland, Ohio. The company has designed a next generation business model that facilitates efficient execution of earlier-stage drug development programs with the objective of out-licensing these significantly enhanced assets to biopharmaceutical companies or venture firms for later-stage development and commercialization.
The company intends to raise $100 million in total initial capital as it builds a portfolio of breakthrough discoveries in-licensed from academic medical centers and other sources. BioMotiv is part of The Harrington Project for Discovery and Development, a first-of-its-kind $250 million initiative announced by University Hospitals (UH) in February.
In conjunction with the launch, BioMotive announced their leadership team.
Click here to read more.
|
|
|
|
|